SENSEYE INC — Department of Defense SBIR Phase I: X224-OCSO1

SENSEYE INC — SBIR Phase I award from Department of Defense.

Amount
$74,985
Agency
Department of Defense · Air Force
Program / Phase
SBIR · Phase I
Topic
X224-OCSO1
Solicitation
X22.4
NAICS
Place of performance
TX
Period
2022-11-01 → 2023-02-04

Description

Technical Abstract:  Senseye is a breakthrough AI-driven diagnostic platform that uses commercially available cameras to capture images of the eye which delivers highly accurate and previously inaccessible and objective data about various aspects of an individual’s mental health. Through our platform, we help clinicians personalize care with fast and accurate tools to establish a clear baseline and track long-term outcomes. By creating objective mental health diagnostics for the first time, we believe it is possible to empower the DOD and Civilian Health Systems with tools to provide better and quicker mental health care to an ever-increasing population, in a preventative manner, and therefore enabling a reduction in suicides.. This is Senseye’s goal, and our mission is to empower all people to manage their mental health successfully. Here we propose to deploy Senseye technology for the purposes of non-invasive, accessible, and empirical detection of Generalized Anxiety Disorder (GAD).